Have a personal or library account? Click to login
Usefulness of CHROMagar Candida Medium, Biochemical Methods – API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification Cover

Usefulness of CHROMagar Candida Medium, Biochemical Methods – API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification

Open Access
|Mar 2016

References

  1. Basssetti M., F. Ansaldi, L. Nicilini, E. Malfatto, M.P. Molinari, M. Mussap, B. Rebesco, F. Bobio Pallavicini, G. Icardi and C. Viscoli. 2009. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J. Antimicrob. Chemother. 64: 625–629.10.1093/jac/dkp25119622536
  2. Bassetti M., E. Righi, A. Costa, R. Fasce, M.P. Molinari, R. Rosso, F.B. Pallavicini and C. Viscoli. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6: 21.10.1186/1471-2334-6-21137964816472387
  3. Campanha N.H., K.H. Neppelenbroek, D.M.P. Spolidorio, L.C. Spolidorio and A.C. Pavarina. 2005. Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Dis. 11: 392–398.10.1111/j.1601-0825.2005.01135.x16269032
  4. Clark R.B., M.A. Lewinski, M.J. Loeffenlholz and R.J. Tibbetts. 2009. Cumitech 31A. Verification and Validation of Procedures in the Clinical Microbiology Laboratory, ed. Sharp S.E. ASM Press, Washington, D.C.
  5. Freydiere A.M., R. Guinet and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39: 9–33.10.1080/mmy.39.1.9.3311270413
  6. Graf B., T. Adam, E. Zill and U.B. Göbel. 2000. Evaluation of the VITEK 2 System for rapid identification of yeast-like organisms. J. Clin. Micriobiol. 38: 1782–1785.10.1128/JCM.38.5.1782-1785.20008658710790099
  7. Kirkpatrick W.R., G.R. Sanjay, R.K. McAtee, J.L. Lopez-Ribot, A.W. Fothergill, D.I. McCarthy, S.E. Sanche, R.A. Cantu, M.G. Rinaldi and T.F. Patterson. 1998. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J. Clin. Microbiol. 36: 3007–3012.10.1128/JCM.36.10.3007-3012.19981051029738058
  8. Levy I., L.G. Rubin, S. Vasishtha, V. Tucci and S.K. Sood. 1998. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin. Infect. Dis. 26: 1086–1088.10.1086/5202779597232
  9. Marklein G., M. Josten, U. Klanke, E. Müller, R. Horré and T. Maier. 2009. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J. Clin. Microbiol. 47: 2912–2917.10.1128/JCM.00389-09273812519571014
  10. Martinez L., J.L. López-Ribot, W.R. Kirkpatrick. B.J. Coco, S.P. Bachmann and T.F. Patterson. 2002. Replacement of Candida albicans with Candida dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal. J. Clin. Microbiol. 40: 3135–313910.1128/JCM.40.9.3135-3139.200213075312202543
  11. Martinez-Lamas L., M.L. Perez del Molino, F. Pardo, E. Varela and B.J. Regueiro. 2011. Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans. Enferme-dades Infecciosa y Microbiologia Clinica. 29: 568–572.10.1016/j.eimc.2011.03.01421782293
  12. Pravin C.M.V., A. Kali. and N.M. Joseph. 2015. Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials. Pharmacognosy Research. 7(Suppl 1): S69–S73.10.4103/0974-8490.150528
  13. Prod’hom A., C. Bizzini, J. Durussel, G. Bille and G. Greub. 2010. Matrix assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J. Clin. Microbiol. 48: 1481–1483.10.1128/JCM.01780-09
  14. Pulcrano G., D.V. Iula, A. Vollaro, A. Tucci, M. Cerullo, M. Esposito, F. Rossano and M.R. Catania. 2013. Rapid and reliable MALDI-TOF mass spectrometry identification Candida nonalbicans isolates from bloodstream infections. J. Microbiol. Methods. 94: 262–266.10.1016/j.mimet.2013.07.001
  15. Ruhnke M., A. Schmidt-Westhausen and J. Morschhauser. 2000. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J. Anti-microb. Chemother. 46: 291–29510.1093/jac/46.2.291
  16. Raut S.H. and A. Varaiya. 2009. Differentiation of Candida dubliniensis on chrom agar and Pal’s agar. Indian J. Med. Microbiol. 27: 55–58.10.1016/S0255-0857(21)01756-4
  17. Sow D., B. Fall, M. Ndiaye, B.S. Ba, K. Sylla, R. Tine, A.C. Lô, A. Abiola, B. Wade, T. Dieng and others. 2015. Usefulness of MALDI-TOF mass spectrometry for routine identification of Candida species in a resource-poor setting. Mycopathologia 180: 173–179.10.1007/s11046-015-9905-226016846
  18. Sullivan D. and D. Coleman. 1998. Candida dubliniensis: Characteristics and identification. J. Clin. Microbiol. 36:329–334.10.1128/JCM.36.2.329-334.19981045379466736
  19. Van Veen S.Q., E.C. Claas and E.J. Kuijper. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization time-of-flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48: 900–907.10.1128/JCM.02071-09283242920053859
DOI: https://doi.org/10.5604/17331331.1197283 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 111 - 114
Submitted on: Sep 10, 2015
Accepted on: Nov 30, 2015
Published on: Mar 15, 2016
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 ELŻBIETA STEFANIUK, ANNA BARANIAK, MONIKA FORTUNA, WALERIA HRYNIEWICZ, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.